PGI16 COST-EFFECTIVENESS OF ON-TREATMENT MONITORING OF HBSAG LEVELS TO PREDICT RESPONSE TO PEGINTERFERON-ALPHA-2A FOR HEPATITIS B TREATMENT UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72499-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)72499-8/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
656
First Page :
A371
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72499-8&doi=10.1016/S1098-3015(11)72499-8